[
DCMC Session
|
Presentation
]

Lightning Talks: Real World Use Cases and Solutions for Digital Tech Transfer | Digital CMC Basecamp On-Demand | Basel, Switzerland | Presentation

Learn how Bayer is using a platform knowledge approach to accelerate tech transfer timelines.

See what an expert consulting team has learned from helping top drug developers transition to Digital CMC.

Explore how innovators are navigating upfront planning, expectation management, and data model alignment.

Hear how these experienced teams are starting to navigate program scale-up.

Digital CMC specialists deliver quick-fire insights on how they're streamlining tech transfer workflows.

To close out Basecamp Basel, experts from drug development and life science consulting took the stage to share learnings, best practices, and quantifiable results from their digitization initiatives.

In this series of snapshot presentations:

  • Florian Aupert and Isabelle Hagemann from Bayer Pharmaceuticals share how their site deployed QbDVision-based platform approach that helped them shorten tech transfer timelines, reduce meetings, save significant costs, and more.
  • Paul Denny-Gouldson from Zifo R&D shares how his team approaches unifying data strategies, addressing data silos and legacy systems, improving digital literacy, and balancing science with digital transformation.

Sign up today to watch their full presentations and audience Q&A!

Session speakers

6 photos

Watch this session

Legend
Legend
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

We’re here to help you deliver

No items found.
[
Bayer AG
]

Florian Aupert

Florian has a B. Sc. and M. Sc. in pharmaceutical biotechnology with a focus on bioprocess engineering. Since 2018, he's worked at Bayer AG in Biological Development, concentrating on portfolio program management and tech transfer.

[
Bayer AG
]

Isabell Hagemann

Isabell Hagemann is a biochemical engineer by training and has worked at Bayer AG in the biological development downstream department in 2017. In that time, she has worked on process development, process characterization, and the technology transfers of several biologics using high-throughput development systems, modeling approaches, and knowledge management tools.

[
Novartis
]

Laurent Lefebvre

Laurent is the Director of RA GDD CMC at Novartis. With over 10 years of experience working as a worldwide Regulatory CMC Project Lead on blockbuster brands, he is an expert in the entire CMC product lifecycle in global regulatory environments. Laurent has been a core team member of the Novartis Regulatory Strategy and Intelligence for IDMP since 2014 and a member of the EFPIA ICH M4Q support team. He is involved in regular collaborations cross-industry (IDMP roundtables, Pistoia Alliance), digital initiatives (RIM structured authoring, master data & PLM), reviewer of the ISO IDMP guidelines and a Novartis contributor to regulatory intelligence discussions.

[
Zifo
]

Paul Denny-Gouldson

Paul is the CSO at Zifo RnD Solutions, a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains. He obtained his Ph.D. in Computational Biology from Essex University in 1996 and started his career as a Post Doc, and subsequently Senior Scientist at Sanofi-Synthelabo Toulouse (now Sanofi) for five years, where he managed a multidisciplinary molecular and cell biology department. He has also founded a number of companies focused on combining science, technology and business, and authored more than 25 scientific papers and book chapters.